<PAGE> 1
AMENDMENT 1 TO SECOND QUARTER 10-Q
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_____________
FORM 10-Q/A
_____________
Amendment No. 1
[X] AMENDMENT TO QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF
THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended
January 31, 1996
or
[ ] AMENDMENT TO TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF
THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from
_________________ to ________________
Commission file number: 0-14491
ARBOR DRUGS, INC.
- ------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
Michigan 38-2054345
-------------------------------- -------------------
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
3331 West Big Beaver, Troy, Michigan 48084 (810) 643-9420
- ------------------------------------------------------------------------------
(Address, Including Zip Code, and Telephone Number, Including Area Code of
Registrant's Principal Executive Offices)
Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.
Yes X No
-------- --------
Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the latest practicable date.
Class Outstanding at February 27, 1996
---------------------------- --------------------------------
Common Stock, $.01 par value 25,015,508
<PAGE> 2
Reason for filing Form 10-Q (Amendment 1)
Form 10-Q Amendment 1 is being filed for the second quarter of fiscal 1996 for
EDGAR Filing Inc. because when Form 10-Q was filed on February 27, 1996,
Exhibit 27 included income statement data for the three months ended January
31, 1996 and should have included income statement data for the six months
ended January 31, 1996.
<PAGE> 3
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
(a) Exhibit 11: Computation of Earnings Per Share Page 12
Exhibit 27: Financial Data Schedule
(b) Reports on Form 8-K:
None
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
ARBOR DRUGS, INC.
-----------------
(Registrant)
DATED: March 4, 1996 /s/ Gilbert C. Gerhard
------------- -----------------------
Gilbert C. Gerhard
(Duly Authorized Officer and
Principal Financial Officer)
<TABLE> <S> <C>
<ARTICLE> 5
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> JUL-31-1996
<PERIOD-START> NOV-01-1995
<PERIOD-END> JAN-31-1996
<CASH> 41,500
<SECURITIES> 160
<RECEIVABLES> 20,254
<ALLOWANCES> 0
<INVENTORY> 103,061
<CURRENT-ASSETS> 168,634
<PP&E> 131,828
<DEPRECIATION> 53,287
<TOTAL-ASSETS> 268,367
<CURRENT-LIABILITIES> 75,212
<BONDS> 21,536
0
0
<COMMON> 250
<OTHER-SE> 164,790
<TOTAL-LIABILITY-AND-EQUITY> 268,367
<SALES> 405,205
<TOTAL-REVENUES> 405,205
<CGS> 299,524
<TOTAL-COSTS> 299,524
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 972
<INCOME-PRETAX> 21,069
<INCOME-TAX> 7,233
<INCOME-CONTINUING> 13,836
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 13,836
<EPS-PRIMARY> .56
<EPS-DILUTED> .54
</TABLE>
